Chapter 10

An Industry Perspective: Medical Device Epidemiology and Surveillance

Martha A. Feldman RAC

Martha A. Feldman RAC

President and CEO, Drug & Device Development Co, Inc., PO Box 3515, Redmond, WA 98073-3515, USA

Search for more papers by this author
First published: 02 March 2007

Summary

This chapter contains sections titled:

  • Introduction

  • The product's life cycle: premarket (preclinical and clinical) and postmarket (PM) studies

  • Postmarket studies

  • Summary

  • References

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.